2023 Q3 Form 10-Q Financial Statement

#000121390023059041 Filed on July 24, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $0.00 $10.00K $6.309K
YoY Change -100.0% 58.5% -73.64%
Cost Of Revenue $80.00K $15.00K $13.43K
YoY Change 388.4% 11.73% -72.77%
Gross Profit -$80.00K -$5.000K -$7.116K
YoY Change 1216.44% -29.74% -71.96%
Gross Profit Margin -50.0% -112.79%
Selling, General & Admin $342.0K $508.0K $850.4K
YoY Change -38.46% -40.26% 15.39%
% of Gross Profit
Research & Development $287.0K $207.0K $166.8K
YoY Change 17.6% 24.1% 106.96%
% of Gross Profit
Depreciation & Amortization $26.00K $26.00K $18.22K
YoY Change 36.7% 42.7% 2266.23%
% of Gross Profit
Operating Expenses $629.0K $715.0K $1.017M
YoY Change -21.36% -29.71% 24.42%
Operating Profit -$709.0K -$720.0K -$1.024M
YoY Change -12.02% -29.71% 21.52%
Interest Expense $412.0K $428.0K $81.26K
YoY Change 179.35% 426.68% -69.85%
% of Operating Profit
Other Income/Expense, Net $1.000K $7.000K
YoY Change
Pretax Income -$1.120M -$1.141M -$552.2K
YoY Change 46.22% 106.63% -39.03%
Income Tax
% Of Pretax Income
Net Earnings -$1.120M -$1.141M -$552.2K
YoY Change 46.22% 106.63% -39.03%
Net Earnings / Revenue -11410.0% -8752.59%
Basic Earnings Per Share -$0.01 -$0.01 -$0.01
Diluted Earnings Per Share -$0.01 -$0.01 -$0.01
COMMON SHARES
Basic Shares Outstanding 98.20M shares 96.98M shares 84.27M shares
Diluted Shares Outstanding 98.33M shares 96.04M shares 84.27M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $52.00K $50.00K $20.83K
YoY Change -52.2% 140.04% -88.9%
Cash & Equivalents $52.00K $50.00K $20.83K
Short-Term Investments
Other Short-Term Assets $28.00K $129.0K $202.6K
YoY Change -74.22% -36.32% 120.79%
Inventory $101.0K $162.0K $163.7K
Prepaid Expenses $78.99K
Receivables
Other Receivables
Total Short-Term Assets $181.0K $341.0K $387.1K
YoY Change -51.35% -11.9% -4.18%
LONG-TERM ASSETS
Property, Plant & Equipment $430.0K $458.0K $488.9K
YoY Change -8.48% -6.32% -57.79%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $160.0K $160.0K $133.0K
YoY Change 0.25% 20.3% -16.67%
Total Long-Term Assets $1.307M $1.385M $1.578M
YoY Change -15.16% -12.24% 19.75%
TOTAL ASSETS
Total Short-Term Assets $181.0K $341.0K $387.1K
Total Long-Term Assets $1.307M $1.385M $1.578M
Total Assets $1.488M $1.726M $1.965M
YoY Change -22.2% -12.17% 14.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.621M $2.762M $1.980M
YoY Change 33.39% 39.46% 4.63%
Accrued Expenses $2.129M $1.794M $1.595M
YoY Change 26.04% 12.48% -5.62%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $9.214M $9.211M $8.350M
YoY Change 12.33% 10.31% -33.07%
Total Short-Term Liabilities $14.63M $14.43M $12.83M
YoY Change 16.35% 12.51% -22.25%
LONG-TERM LIABILITIES
Long-Term Debt $7.218M $7.238M $8.406M
YoY Change -13.93% -13.9% 80.81%
Other Long-Term Liabilities $545.0K $603.0K $817.8K
YoY Change -28.93% -26.27% -18.54%
Total Long-Term Liabilities $7.763M $7.841M $9.224M
YoY Change -15.19% -15.0% 63.17%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.63M $14.43M $12.83M
Total Long-Term Liabilities $7.763M $7.841M $9.224M
Total Liabilities $22.40M $22.27M $22.05M
YoY Change 3.07% 1.0% -0.45%
SHAREHOLDERS EQUITY
Retained Earnings -$477.0M -$475.9M -$471.9M
YoY Change 0.92% 0.85%
Common Stock $10.00K $9.000K $8.524K
YoY Change 12.13% 5.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$20.91M -$20.55M -$20.09M
YoY Change
Total Liabilities & Shareholders Equity $1.488M $1.726M $1.965M
YoY Change -22.2% -12.17% 14.13%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$1.120M -$1.141M -$552.2K
YoY Change 46.22% 106.63% -39.03%
Depreciation, Depletion And Amortization $26.00K $26.00K $18.22K
YoY Change 36.7% 42.7% 2266.23%
Cash From Operating Activities -$735.0K -$797.0K -$722.5K
YoY Change -5.3% 10.31% 36.14%
INVESTING ACTIVITIES
Capital Expenditures -$1.000K $1.000K $22.57K
YoY Change -95.57% 36.61%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $1.000K -$1.000K -$22.57K
YoY Change -95.57% 36.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $634.8K
YoY Change 124.3%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 736.0K $833.0K $615.7K
YoY Change -14.83% 35.3% 78.85%
NET CHANGE
Cash From Operating Activities -735.0K -$797.0K -$722.5K
Cash From Investing Activities 1.000K -1.000K -22.57K
Cash From Financing Activities 736.0K $833.0K $615.7K
Net Change In Cash 2.000K $36.00K -$106.8K
YoY Change -97.73% -133.7% -42.72%
FREE CASH FLOW
Cash From Operating Activities -$735.0K -$797.0K -$722.5K
Capital Expenditures -$1.000K $1.000K $22.57K
Free Cash Flow -$734.0K -$798.0K -$745.1K
YoY Change -5.43% 7.1% 36.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-05-31
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
AURA SYSTEMS, INC.
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
95-4106894
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
20431 North Sea Circle
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Lake Forest
CY2023Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92630
CY2023Q2 dei City Area Code
CityAreaCode
(310)
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
643-5300
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
98204406 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
162000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
155000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
129000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
142000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
341000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
312000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
458000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
461000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
767000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
816000 usd
CY2023Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
160000 usd
CY2023Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
160000 usd
CY2023Q2 us-gaap Assets
Assets
1726000 usd
CY2023Q1 us-gaap Assets
Assets
1749000 usd
CY2023Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
370000 usd
CY2023Q1 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
376000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2762000 usd
CY2023Q2 us-gaap Revenues
Revenues
10000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2758000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1382000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
995000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1794000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1389000 usd
CY2023Q2 us-gaap Customer Advances Current
CustomerAdvancesCurrent
447000 usd
CY2023Q1 us-gaap Customer Advances Current
CustomerAdvancesCurrent
454000 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1403000 usd
CY2023Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1403000 usd
CY2023Q2 ausi Convertible Note Payablesrelated Party Past Due
ConvertibleNotePayablesrelatedPartyPastDue
3000000 usd
CY2023Q1 ausi Convertible Note Payablesrelated Party Past Due
ConvertibleNotePayablesrelatedPartyPastDue
3000000 usd
CY2023Q2 us-gaap Notes Payable To Bank Current
NotesPayableToBankCurrent
92000 usd
CY2023Q1 us-gaap Notes Payable To Bank Current
NotesPayableToBankCurrent
92000 usd
CY2023Q2 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
4716000 usd
CY2023Q1 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
4714000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
214000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
207000 usd
CY2023Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
3000 usd
CY2023Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
9000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
14431000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
14026000 usd
CY2023Q2 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
235000 usd
CY2023Q1 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
256000 usd
CY2023Q2 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
7003000 usd
CY2023Q1 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
7065000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
603000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
660000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
22272000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
22007000 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
97234708 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
97234708 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
94648346 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
94648346 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
9000 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
9000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
455360000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
454507000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-475915000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-474774000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-20546000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-20258000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1726000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1749000 usd
CY2022Q2 us-gaap Revenues
Revenues
6000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
-5000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
-7000 usd
CY2023Q2 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
36000 usd
CY2022Q2 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
35000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
207000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
167000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
508000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
850000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
715000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
1017000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-720000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1024000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
428000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
81000 usd
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7000 usd
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-553000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1141000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-552000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
96036536 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84273089 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-21219000 usd
CY2022Q2 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
635000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Mark To Market
AdjustmentsToAdditionalPaidInCapitalMarkToMarket
1051000 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-552000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-20085000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-20258000 usd
CY2023Q2 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
853000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1141000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-20546000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1141000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-552000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
26000 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
18000 usd
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7000 usd
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-553000 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7000 usd
CY2022Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
19000 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9000 usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-53000 usd
CY2022Q2 us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
-27000 usd
CY2023Q2 ausi Increase Decrease In Operating Lease Rightofuse Asset
IncreaseDecreaseInOperatingLeaseRightofuseAsset
-49000 usd
CY2022Q2 ausi Increase Decrease In Operating Lease Rightofuse Asset
IncreaseDecreaseInOperatingLeaseRightofuseAsset
-44000 usd
CY2023Q2 us-gaap Increase Decrease In Payables To Customers
IncreaseDecreaseInPayablesToCustomers
-3000 usd
CY2022Q2 us-gaap Increase Decrease In Payables To Customers
IncreaseDecreaseInPayablesToCustomers
244000 usd
CY2023Q2 us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
345000 usd
CY2022Q2 us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
59000 usd
CY2023Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-50000 usd
CY2022Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-43000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-797000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-722000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1000 usd
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
23000 usd
CY2023Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
853000 usd
CY2022Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
635000 usd
CY2023Q2 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
20000 usd
CY2022Q2 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
19000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
833000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
616000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
35000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-129000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
150000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21000 usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
67000 usd
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
39000 usd
CY2023Q2 us-gaap Stock Issued1
StockIssued1
22000 usd
CY2023Q2 ausi Acquisition Of Property And Equipment With Note Payable
AcquisitionOfPropertyAndEquipmentWithNotePayable
62000 usd
CY2022Q2 ausi Fair Value Of Warrants Issued For Note Settlement
FairValueOfWarrantsIssuedForNoteSettlement
1051000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
1141000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
797000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-20546000 usd
CY2023Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
4403 usd
CY2023Q2 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reported periods. Significant estimates include assumptions made for inventory reserve, impairment testing of long-lived assets, the valuation allowance for deferred tax assets, assumptions used in valuing derivative liabilities, assumptions used in valuing share-based compensation, and accruals for potential liabilities. Amounts could materially change in the future. Actual results could differ from those estimates.</p>
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
3000 usd
CY2023Q2 us-gaap Other Liabilities
OtherLiabilities
3000 usd
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
9000 usd
CY2023Q1 us-gaap Other Liabilities
OtherLiabilities
9000 usd
CY2023Q2 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt"><b><i>Reclassifications</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">Certain February 28, 2023 balances have been reclassified to conform with the May 31, 2023 presentation. In presenting the Company’s consolidated balance sheet at February 28, 2023, the Company originally presented accrued interest of $1,389 and accrued payroll and expenses of $441, totaling $1,830 as a separate line item called Accrued Expenses. In presenting the Company’s consolidated balance sheet at May 31, 2023, the Company has reclassified the balance of accrued interest of $1,389 as a separate line item, and the balance of accrued payroll and expenses of $441 as part of accounts payable and accrued expense in the accompanying February 28, 2023 financial statements.</span></p>
CY2023 us-gaap Interest Expense Other
InterestExpenseOther
1389000 usd
CY2023Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
441000 usd
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1830000 usd
CY2023Q2 us-gaap Interest Expense Other
InterestExpenseOther
1389000 usd
CY2023Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
441000 usd
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11761578 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16942228 shares
CY2023Q2 ausi Convertible Note Payable
ConvertibleNotePayable
1403000 usd
CY2023Q1 ausi Convertible Note Payable
ConvertibleNotePayable
1403000 usd
CY2023Q2 ausi Convertible Note Payable Current
ConvertibleNotePayableCurrent
1403000 usd
CY2023Q1 ausi Convertible Note Payable Current
ConvertibleNotePayableCurrent
1403000 usd
CY2023Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
4000000 usd
CY2023Q2 us-gaap Accounts Payable Interest Bearing Interest Rate
AccountsPayableInterestBearingInterestRate
0.05 pure
CY2023Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
1.4
CY2023Q2 us-gaap Debt Instrument Maturity Date Description
DebtInstrumentMaturityDateDescription
The notes were originally due in 2014 to 2017, and were all amended in 2018 and the maturity date for all the notes was changed to January 11, 2023.
CY2023Q2 us-gaap Debt Instrument Annual Principal Payment
DebtInstrumentAnnualPrincipalPayment
1403000 usd
CY2023Q1 us-gaap Debt Instrument Annual Principal Payment
DebtInstrumentAnnualPrincipalPayment
1403000 usd
CY2023Q2 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
372000 usd
CY2023 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
354000 usd
CY2023Q1 us-gaap Convertible Debt
ConvertibleDebt
3000000 usd
CY2022Q1 us-gaap Convertible Debt
ConvertibleDebt
3000000 usd
CY2023Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
3000000 usd
CY2022Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
3000000 usd
CY2017Q1 us-gaap Convertible Subordinated Debt
ConvertibleSubordinatedDebt
3000000 usd
CY2017Q1 us-gaap Debt Instrument Interest Rate Increase Decrease
DebtInstrumentInterestRateIncreaseDecrease
0.05 pure
CY2017Q1 us-gaap Debt Instrument Convertible Conversion Price Decrease
DebtInstrumentConvertibleConversionPriceDecrease
1.4
CY2023Q2 us-gaap Convertible Subordinated Debt
ConvertibleSubordinatedDebt
3000000 usd
CY2023Q2 us-gaap Income Tax Examination Interest Accrued
IncomeTaxExaminationInterestAccrued
751000 usd
CY2023Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
751000 usd
CY2022Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
713000 usd
CY2023Q2 ausi Total Notes Payable
TotalNotesPayable
327000 usd
CY2023Q1 ausi Total Notes Payable
TotalNotesPayable
348000 usd
CY2023Q2 ausi Unsecured Notes Payable Non Current
UnsecuredNotesPayableNonCurrent
235000 usd
CY2023Q1 ausi Unsecured Notes Payable Non Current
UnsecuredNotesPayableNonCurrent
256000 usd
CY2023Q2 ausi Total Notes Payable Current
TotalNotesPayableCurrent
92000 usd
CY2023Q1 ausi Total Notes Payable Current
TotalNotesPayableCurrent
92000 usd
CY2020Q3 ausi Description Of Economic Injury Disaster Loan
DescriptionOfEconomicInjuryDisasterLoan
the Company received a $150 loan under the United States Small Business Administration (“SBA”) Economic Injury Disaster Loan (“EID Loan”) program. The loan is due July 1, 2050, interest accrues at 3.75% per annum, and is secured by the assets of the Company.
CY2022 ausi Description Of Notes Payable Vehicle And Equipment
DescriptionOfNotesPayableVehicleAndEquipment
During Fiscal 2022, the Company issued notes payable to purchase two pieces of equipment and a vehicle for $329. The notes are secured by the equipment and vehicle purchased. One note for $210 is due October 31, 2024, and requires 36 equal monthly payments of approximately $6 each, including interest at 2.9% per annum. The second note for $78 is due January 20, 2027, and requires 72 equal monthly payments of approximately $1.5 each, including interest at 10.9% interest per annum. As of May 31, 2023 and February 28, 2023, the balance of the two notes was approximately $167 and $188, respectively.
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
10000 usd
CY2023 us-gaap Interest Expense Debt
InterestExpenseDebt
10000 usd
CY2023Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
11719000 usd
CY2023Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
11779000 usd
CY2023Q2 ausi Note Payable Noncurrent
NotePayableNoncurrent
7003000 usd
CY2023Q1 ausi Note Payable Noncurrent
NotePayableNoncurrent
7065000 usd
CY2023Q2 ausi Note Payable Current
NotePayableCurrent
4716000 usd
CY2023Q1 ausi Note Payable Current
NotePayableCurrent
4714000 usd
CY2023Q2 ausi Aggregate Amount
AggregateAmount
1000000 usd
CY2022Q2 ausi Due Realted Parties Paid
DueRealtedPartiesPaid
150000 usd
CY2023Q1 us-gaap Related Party Transaction Rate
RelatedPartyTransactionRate
0.06 pure
CY2023Q1 ausi Incurred Extension And Forbearance Fees Payment
incurredExtensionAndForbearanceFeesPayment
60000 usd
CY2023Q1 ausi Extension Fees
ExtensionFees
2850000 usd
CY2023Q1 us-gaap Financing Receivable Modification To Total Financing Receivables Excluding Accrued Interest Percent
FinancingReceivableModificationToTotalFinancingReceivablesExcludingAccruedInterestPercent
0.06 pure
CY2023Q2 us-gaap Related Party Transaction Rate
RelatedPartyTransactionRate
0.06 pure
CY2014Q2 ausi Bears Interest Rate
BearsInterestRate
0.10 pure
CY2023Q2 ausi Claimed Notes Payable And Accrued Interest
ClaimedNotesPayableAndAccruedInterest
166000 usd
CY2023 ausi Claimed Notes Payable And Accrued Interest
ClaimedNotesPayableAndAccruedInterest
164000 usd
CY2023Q2 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
372000 usd
CY2023Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
354000 usd
CY2023Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
751000 usd
CY2023Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
713000 usd
CY2023Q2 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
631000 usd
CY2023Q1 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
282000 usd
CY2023Q2 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
22000 usd
CY2023Q1 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
23000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
18000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
17000 usd
CY2023Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1794000 usd
CY2023Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1389000 usd
CY2023Q2 ausi Square Foot
SquareFoot
18000 sqft
CY2023Q2 dei Document Description
DocumentDescription
The initial monthly base rental rate was approximately $22 per month and escalates 3% each year to approximately $26 per month in 2026.
CY2023Q2 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.10 pure
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
70000 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
70000 usd
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
71000 usd
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
69000 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y3M
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y3M
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10 pure
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10 pure
CY2023Q2 ausi Longterm Rightofuse Assets
LongtermRightofuseAssets
767000 usd
CY2023Q2 ausi Shortterm Operating Lease Liabilities
ShorttermOperatingLeaseLiabilities
214000 usd
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
603000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
817000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
212000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
291000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
300000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
154000 usd
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
957000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
140000 usd
CY2023Q2 ausi Present Value Of Lease Liabilities
PresentValueOfLeaseLiabilities
817000 usd
CY2023Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
853000 usd
CY2023Q1 ausi Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber
3564764 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.86
CY2023Q2 ausi Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber
3564764 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.86
CY2023Q2 us-gaap Debt Instrument Term
DebtInstrumentTerm
P7Y
CY2023Q2 us-gaap Warrant Exercise Price Increase
WarrantExercisePriceIncrease
0.85
CY2023Q2 us-gaap Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
1051000 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.85
CY2022Q2 us-gaap Share Price
SharePrice
0.317
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.25 pure
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0198 pure
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023Q2 us-gaap Interest Costs Incurred
InterestCostsIncurred
36000 usd
CY2022Q2 us-gaap Interest Costs Incurred
InterestCostsIncurred
35000 usd
CY2023Q2 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
231000 usd
CY2023Q1 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
216000 usd
CY2021Q3 us-gaap Principal Amount Outstanding On Loans Held For Sale Or Securitization
PrincipalAmountOutstandingOnLoansHeldForSaleOrSecuritization
330000 usd
CY2023Q2 us-gaap Litigation Settlement Amount Awarded From Other Party
LitigationSettlementAmountAwardedFromOtherParty
277000 usd
CY2023Q2 us-gaap Compensating Balance Amount
CompensatingBalanceAmount
53000 usd
CY2023Q2 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2023-09-01
CY2023Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.10 pure
CY2022Q1 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
13000000 usd
CY2022Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
23000000 shares
CY2022Q1 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P7Y
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.1
CY2023Q2 ausi Description Of Loan Fees And Late Payment
DescriptionOfLoanFeesAndLatePayment
Under the terms of the settlement, the Company agreed to pay an aggregate amount of $10,000, including an initial amount of $3,000 due in June 2022, which was subsequently extended to August 1, 2023. In June, 2022, the Company paid $150 of the initial amount. All amounts, including all accrued interest and accrued forbearance fees, are to be paid no later than eight years from the date of the initial payment. The settlement also provides for standard mutual general release provisions and includes customary representations, warranties, and covenants, including certain increases in the amount payable to the Kopple Parties and the right of such parties to enter judgment against the Company if the Company remains in uncured default in its payment obligations under the settlement. As of the date of this report, the Company has not yet paid the $2,850 balance of the initial installment (see Note 6).
CY2023Q2 ausi Balance Due On The Initial Payment
BalanceDueOnTheInitialPayment
2850000 usd
CY2023Q2 us-gaap Payments For Fees
PaymentsForFees
30000 usd
CY2023Q2 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
100000 usd
CY2023Q2 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
969698 shares
CY2023Q2 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
320000 usd
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84273089 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
96036536 shares
CY2023Q2 us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
usd
CY2023Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022Q2 us-gaap Stock Issued1
StockIssued1
usd
CY2022Q2 ausi Acquisition Of Property And Equipment With Note Payable
AcquisitionOfPropertyAndEquipmentWithNotePayable
usd
CY2023Q2 ausi Fair Value Of Warrants Issued For Note Settlement
FairValueOfWarrantsIssuedForNoteSettlement
usd
CY2023Q2 ausi Convertible Notes Payable Noncurrent
ConvertibleNotesPayableNoncurrent
usd
CY2023Q1 ausi Convertible Notes Payable Noncurrent
ConvertibleNotesPayableNoncurrent
usd
CY2023Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
usd
CY2022Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
CY2023Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-28
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000826253
CY2023Q2 dei Entity File Number
EntityFileNumber
0-17249

Files In Submission

Name View Source Status
0001213900-23-059041-index-headers.html Edgar Link pending
0001213900-23-059041-index.html Edgar Link pending
0001213900-23-059041.txt Edgar Link pending
0001213900-23-059041-xbrl.zip Edgar Link pending
ausi-20230531.xsd Edgar Link pending
f10q0523ex31-1_aurasystems.htm Edgar Link pending
f10q0523ex31-2_aurasystems.htm Edgar Link pending
f10q0523ex32-1_aurasystems.htm Edgar Link pending
f10q0523_aurasystems.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
ausi-20230531_cal.xml Edgar Link unprocessable
ausi-20230531_def.xml Edgar Link unprocessable
ausi-20230531_pre.xml Edgar Link unprocessable
ausi-20230531_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
f10q0523_aurasystems_htm.xml Edgar Link completed
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending